A Trial of HRS-3095 in Healthy Volunteers

Recruiting Early Phase 1 Interventional Study
Chronic Spontaneous Urticaria
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 55
Sex
Any
Trial phase
Early Phase 1
Study type
Interventional
Purpose
Treatment
Participants needed
36 (estimated)
Sponsor
Atridia Pty Ltd. · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The purpose of this study is to assess safety, PK, Pharmacodynamic profile of a single dose of HRS-3095 in healthy participants

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Main inclusion criteria 1. Healthy white participants. 2. Male or female aged between 18 years and 55 years (inclusive) 3. Ability to understand the trial procedures and possible adverse events, volunteer to participate in the trial, and provide written informed consent, be able to comply with all …
Contacts

Kathy You

+61 02 9299 0433

kathyyou@atridia.com

CONTACT

Eimy Minowa

+61 432223162

eimy.minowa@atridia.com

CONTACT